Section IV false horse tails

Any anabolic steroid in halter classes, section (2) below does not apply.

(an NSAID) The maximum permitted plasma concentration of Flunixin is 1.0 microgram per milliliter.

Subject to the specified restrictions, only those thirteen (13) drugs or medications listed in section (3)(C)(113) below may be administered within 24 hours of showing. The provisions in (3)(C)(113) below contain rules concerning maximum allowable plasma concentration levels followed by Guidelines.

Tails may be lengthened by hair to hair attachment only with no attachments of any kind to the tailbone.

poling (altering an obstacle while the horse is negotiating the obstacle);

Presence of such medication or drug in a horse participating in an AQHAapproved event shall be grounds for the Executive Committee to take the following action if it is determined that the use of said drug or medication was not within the guidelines set forth in the Therapeutic Medication Addendum following subsection (j) of this rule:

AQHA members on the show grounds of an event held in conjunction with an AQHAapproved event; and

tieing or stening any foreign object onto a horse, halter, bridle and/or saddle in order to desensitize the horse;

This prohibition against inhumane treatment applies to AQHA members and nonmembers. AQHA members may be held responsible for the actions of their trainers, agents, representatives and/or employees. For violation of this rule, an individual may be disciplined, suspended, fined, denied AQHA privileges, disqualified, expelled from show grounds and/or expelled from AQHA.

When Ketoprofen (Ketofen®) is administered, the dose should be accurately calculated according to the actual weight of the animal. Each 24 hours, not more than 1.0 milligram per pound of body weight should be administered. For a 1,000 pound animal, the maximum daily dose is 1.0 gram, which equals 10.0 cc of the injectable (100 milligrams per milliliter). No part of a dose should be administered during the twelve (12) hours prior to competing. The medication should not be used for more than five successive days.

Only those thirteen (13) drugs or medications listed in section (3)(C)(113) below may be administered within 24 hours of showing:

schooling using rails higher than four (4) feet;

Bar the horse from participation in further AQHAapproved events or shows for such period as determined appropriate, and, upon request, the owner shall deliver the horses registration certificate to AQHA to be held during the period of the horses suspension from participation. Although ownership of such horse may, thereafter, be transferred to another party, the transfer of ownership will not dissolve or shorten the terms of these suspensions; and

Any nonsteriodal antiinflammatory drug (NSAID) other than those listed in section (3)(C)(18) below.

Date and time of administration.

Diagnosis of illness/injury, reason for administration, and name of administering and/or prescribing AAEP veterinarian.

Violation of this rule is grounds for the Executive Committee, or an appropriate committee of the Association, to bar the horse from future participation in AQHAapproved events or shows for such period as determined appropriate, and upon request, the owner shall deliver the horses registration certificate to AQHA for such ineligibility to be prominently marked on the ce of the registration certificate. Although ownership of the horse may thereafter be transferred to another party, the transfer of ownership will not dissolve or shorten the term of ineligibility.

Identification of the horse: name, age, , color and entry number.

A horse found to have abnormal tail function or appearance may have its participation privileges reinstated if,Wraped horse hair tail extensio, upon examination by AQHAs approved veterinarians, the tail is found to be normal in both appearance and function. A minimum of one year from the time of suspension of privileges must elapse before the horse is eligible for re-examination at the owners expense. After such examination, participation privileges of the horse will remain suspended until reconsideration by the Executive Committee or any appropriate committee of the Association, which the owner must request in writing. The owner shall have the burden of persuasion to prove normal tail function and appearance.

excessive fencing;

EXHIBITORS, OWNERS, TRAINERS AND VETERINARIANS ARE CAUTIONED AGAINST THE USE OF MEDICINAL PREPARATIONS, TONICS, PASTES AND PRODUCTS OF ANY KIND, THE INGREDIENTS AND QUANTITATIVE ANALYSIS OF WHICH ARE NOT SPECIFICALLY KNOWN, AS MANY OF THEM MAY CONTAIN A FORBIDDEN SUBSTANCE.

. Inhumane treatment of any horse (whether registered with AQHA or not) or any other animal on show grounds is strictly prohibited. Treatment of any horse will be considered inhumane if a person, educated or experienced in accepted equine training techniques, would perceive the conduct of an individual to be inhumane. Inhumane treatment includes, but is not limited to:

Restrictions concerning the use of conditionally permitted therapeutic medications that may be administered within 24 hours of showing:

Any drug or substance considered a Class I or Class II substance as defined in the most recent edition of ARCIs Uniform Classification Guidelines for Foreign Substances.

Each of the following requirements is a condition to authorize administration of conditionally permitted therapeutic medications, which shall be verified in a written medication report, available from AQHA or show management, completed in its entirety, and filed with show management before exhibition of the horse (see C through J below):

Padding classes by entering a horse(s) not otherwise qualified for the competition to fill a class, to increase points.

The horse must be withdrawn and kept out of competition for not less than 24 hours after the medication is administered.

(an NSAID) The maximum permitted plasma concentration of phenylbutazone is 15.0 micrograms per milliliter.

he/she designates himself/herself on the entry blank as exhibitor, or authorizes another to designate him as exhibitor on the entry blank;

he/she physically participates in the event by riding or showing the horse; or

Pending final hearing by the Executive Committee or such other appropriate hearing committee, AQHAs Executive Vice President may, by giving written notice of action to the record owner at his current address as shown on AQHA records, temporarily suspend a horse from further participation in an AQHAapproved event or show, and request the return of its registration certificate, if preliminary examination indicates a violation of this rule.

Not withstanding the general prohibition of this rule against artificial appliances, the use of a pacemaker or prosthetic eye may be permitted if the owner files written request for permission and submits documentation as requested, which request will then be submitted to AQHAs Executive Committee for consideration, after which, if the request is approved, such authorization will be noted on the horses registration certificate.

THERAPEUTIC MEDICATION ADDENDUM (DOES NOT APPLY IF PROHIBITED BY GOVERNMENTAL REGULATIONS)

For violation of this rule, an AQHA member may be disciplined, suspended, fined and/or expelled from AQHA, and a nonmember may be denied AQHA privileges. Furthermore, violation of this rule shall be grounds for AQHA to disqualify the horse(s) entered by the persons that participate in the scheme or plan prohibited by this rule.

(an NSAID) The maximum permitted plasma concentration of Ketoprofen is 40.0 nanograms per milliliter.

Any surgical procedure or injection of any foreign substance or drug that could affect a horses performance or alter its natural conformation or appearance is prohibited, except for those surgical procedures performed by a duly licensed veterinarian for the sole purpose of protecting the health of the horse. However, no foreign substance or drug which is of such character as could affect a horses performance is acceptable, whether or not administered to protect the health of the horse and, on the contrary, is prohibited. Upon discovery of the existence of prohibited surgery or injection of foreign substance or drug, show management shall immediately report the matter to AQHA.

The use of earplugs or cotton in the horses ears are acceptable.

Encouraging a potential competitor to refrain from entering the class.

exhibiting a horse which appears to be sullen, dull, lethargic, emaciated, drawn or overly tired; or

It is presumed the sample of urine, saliva, blood or other substance tested by the approved laboratory is the one taken from the horse in question, its integrity is preserved, and that all procedures of such collection and preservation, transfer to the laboratory, and analysis of the sample are correct and accurate, and the report received from the laboratory pertains to the sample taken from the horse in question and correctly reflects the condition of the horse during the show in which he was entered, with the burden on the exhibitor or other responsible party to prove otherwise at any hearing in regard to the matter conducted by AQHA.

Pending final hearing by the Executive Committee or such other appropriate hearing committee, the Executive Vice President may, by giving written notice of his action to the owner of record at his current address as shown on AQHA records, temporarily suspend such horse from further participation in an AQHAapproved event or show.

excessive jerking of reins;

An individual is absolutely responsible for a horses condition if:

excessive spurring or whipping;

AQHA representatives may examine any registered American Quarter Horse for an altered tail if entered in any event held in conjunction with an AQHAapproved show, whether or not said event is approved by AQHA.

Every 12 hours, not more than 73 mg of diclofenac liposomal cream should be administered (not more than 146 mg per 24 hour period) to one affected site. This 73 mg dose equals a 5inch ribbon of cream not greater than 1/2 inch in width, which should be rubbed thoroughly into the hair over the joint or affected site using gloved hands. Administration of diclofenac cream should be discontinued 12 hours prior to competing. Do not apply diclofenac cream in combination with any other topical preparations including DMSO, nitrofurazone or liniments, and do not use on an open wound. Diclofenac cream should not be administered for more than 10 successive days.

Forbidden drugs or substances:

leaving a bit in a horses mouth for extended periods of time so as to cause undue discomfort or distress;

While the medication report must be filed only if the administered medication will be present in amounts detectable in blood and/or urine samples at the time of competition/sampling, exhibitors are hereby cautioned it is their responsibility to determine whether or not such medication has had time to clear the horses system.

Regardless of whether all of the conditionally permitted therapeutic medication requirements listed in section 2 are met, it shall be considered a rule violation if the same plasma or urine sample contains more than one (1) of the permitted NSAIDs listed in section (3)(C)(18) below.

HOWEVER, THESE DRUGS OR SUBSTANCES ARE FORBIDDEN AND USE THEREOF SUBJECTS THE PERSON TO DISCIPLINARY ACTION, UNLESS ALL CONDITIONS OF THEIR ADMINISTRATION ARE MET.

tying a horse up or around in a stall in the manner as to cause undue discomfort or distress;

he/she is the actual trainer, having presented or caused to be presented the horse at the show grounds for exhibition. Both the exhibitor designated on the entry blank and one having actual possession of the horse while physically participating with the horse in the event are conclusively presumed to be authorized by the owner to execute all documents, necessary or convenient, to allow the horses participation in an AQHAapproved event, including documents pertaining to drug testing and the use of Lasix. If an individual is prevented from performing his/her duties, including absolute responsibility for the condition of the horse, by illness or otherwise, or is absent from the show, he/she shall immediately notify the show secretary, and appoint a substitute, and such substitute shall place his/her name on the entry blank forthwith. The exhibitor and owner acknowledge an exhibitor represents the owner in regard to his/her horses entered in an approved show.

If a contestant, while inside the show arena or show ring, is assisted in any manner by another person or provides assistance in any manner to another person, the contestant shall automatically be disqualified. This rule does not apply to co-contestants assisting each other in team events such as dally team roping, cutting, team penning or ranch sorting. Furthermore, this rule does not apply to a contestant that assists another contestant if such assistance was necessitated for the safety of competing exhibitors or horses as determined by the judgehowever, the contestant in need of such assistance shall be disqualified.

Any stimulant, depressant, tranquilizer or sedative which could affect the performance of a horse (stimulants and depressants are defined as substances that stimulate or depress the cardiovascular, respiratory or central nervous system).

Intentional or negligent treatment which results in any bleeding.

To assist AQHA in the promotion of true competition, any person approached by another to cooperate in a scheme or plan to inhibit competition shall immediately report the matter to show management and then to AQHA in writing within 10 days, iling which, the person approached may be subject to disciplinary action by the Executive Committee, the same as the person or persons suggesting the scheme or plan.

The medication report must be signed by show management and time of receipt recorded on the report.

(an NSAID) The maximum permitted plasma concentration of Meclofena

The exhibitor, owner and/or absolutely responsible person defined by AQHA rules are each responsible for a horses condition and presumed to know all AQHA rules and regulations and the penalty provisions. Such individuals voluntarily act in entering, exhibiting or causing to be exhibited a horse in an approved show, makes the individual eligible for disciplinary sanctions, whether or not the owner, exhibitor and/or absolutely responsible person had actual knowledge of the surgery or the presence of the foreign substance, drug or trauma, or directly authorized the surgical procedure, injection or had knowledge of the trauma. Purchase and subsequent exhibition of a horse with such condition in an approved show makes an individual responsible under this rule.

use of prohibited equipment, including, but not limited to, saw tooth bits, hock hobbles, tack collars or tack hackamores;

lounging or riding in a manner as to cause undue discomfort or distress;

For the purpose of this rule, normal tail function is defined as being able to raise the tail to or above the horizontal plane. See diagram below. A horses inability to raise its tail to or above the horizontal plane in response to a tail test conducted onsite by an AQHAapproved veterinarian shall be considered a violation of this rule.

Conditionally permitted therapeutic medication: Any drug, medication or substance that could affect the performance of a horse that is used for the legitimate treatment of illness or injury and is not specified as a forbidden substance as defined in sections (1)(A) or (1)(E) above.

The below specified individuals are absolutely responsible for a horses condition, are presumed to know all rules and regulations of AQHA and the penalty provisions of said rules, and their voluntary action in presenting or causing the horse to be presented at show grounds for exhibition, entering a horse or exhibiting one in an approved show, and their absolute responsibility for the condition of the horse makes them eligible for disciplinary sanctions, whether or not they had actual knowledge of the presence of a forbidden drug, directly participated in the administration thereof, innocently miscalculated its retention time in the horses system, or any other reason for its presence is established.

The Guidelines are applicable to most horses. Nevertheless, reliance upon the Guidelines does not guarantee compliance with the rules, since the response of individual horses may vary. Exhibitors, owners, and trainers should consult the drug manucturer and knowledgeable veterinarians for uptodate information and more specific advice concerning the therapeutic use of a drug or medication for a particular horse.

Administration by a veterinarian who is licensed to practice veterinary medicine in the state, province or country where the event is being held (Licensed Veterinarian) or from a written prescription (written instructions) by a Licensed Veterinarian which documents administration of medication is necessary for the legitimate treatment of illness or injury. The administration of a conditionally permitted therapeutic medication for the purpose of transport, grooming, training, etc. is not therapeutic under this authorization rule.

AQHA members on the show grounds of an event during which an AQHAapproved class is held regardless of whether the conduct is associated with or occurs during an AQHAapproved class.

AQHA Stewards (see rule 437.5) may immediately issue a warning or removal cards from show ground to individuals whose conduct is in violation of subsections (a), (c) and/or (d) above and shall file a written report with AQHA concerning the conduct in question. Individuals receiving two (2) warning cards from AQHA Stewards in a twelve (12) month period may be cited to appear before an AQHA hearing committee in accordance with AQHAs disciplinary procedures. Regardless of whether an AQHA Steward is present at the show in question or whether an AQHA Steward takes action regarding violations subsections (a), (c) and/or (d) above, nothing herein prevents show management or AQHA from taking appropriate action with respect to individuals who violate such rules.

placing an object in a horses mouth so as to cause undue discomfort or distress;

Signature of veterinarian or person administering the medication. If by prescription (written instructions), a copy must be attached to the medication report.

The horse shall be disqualified from all classes in which it participates at the show;

Regardless of whether the medication report requirements described above are met, laboratory detection of concentration levels of an otherwise conditionally permitted therapeutic drug that are inconsistent with the administration of a therapeutic dosage of such drug (including, but not limited to, inconsistencies regarding reported dosage and time constraints) shall constitute presumption of a violation of this rule, and the responsible party has the burden of persuasion to establish that the drug was administered in a therapeutic dosage and not less than 24 hours prior to competition.

excessive spinning (defined as no more than eight (8) consecutive turns in either direction);

The definition of an absolutely responsible person as provided in AQHAs rules prohibiting administration, internally or externally of a horse, of medication, drug, mechanical device or artificial appliance pertains also to this rule.

. Unsportsmanlike conduct or any other form of misconduct that is irresponsible, illegal, indecent, prone, intimidating, threatening or abusive is prohibited. This provision applies to:

The responsible individual as defined in this rule may be disciplined under AQHAs general disciplinary procedure or may be offered an administrative penalty as determined appropriate by the Executive Committee.

use of any item or appliance that restricts movement or circulation of the tail;

Paying anothers entry fee, directly or indirectly; or,

he/she signs the entry blank on behalf of himself or another, or causes an agent or representative to sign it;

If, upon examination by AQHA or show representative (after obtaining prior AQHA authorization), horses tail function or appearance is found to be abnormal, the horse shall be immediately reported to AQHA. Upon written notification to the owner by AQHA, the horses participation privileges in AQHAapproved events may be temporarily suspended pending hearing.

. Any form of conduct that inhibits competition at AQHAapproved events is expressly prohibited. This offense includes not only the person suggesting the prohibited conduct, but all who participate in the scheme or plan. Such conduct includes, but is not limited to:

The medication report must be filed with show management within one hour after administration of the medication or one hour after show management is available, if administration occurs at a time other than during competition hours.

Within one year from the filing date by the owner of the trauma report, if the Executive Committee has, in the meantime, barred the horse from participation in AQHAapproved events, or if an owners report has been filed, after one year from the date of Executive Committee action barring the horse, the owner may request, in writing, a reexamination of the horse and rehearing before the Executive Committee for a determination as to whether the horses tail function, carriage, conformation and overall appearance is normal. If the Executive Committees determination is adverse, the owner may repeat his request for reinstatement at the expiration of one year from the date of the latest hearing. The owner shall have the burden of persuasion to prove normal tail function and appearance.

No person shall cause to be administered internally or externally to a horse, either before or during an approved event, any medication, drug, mechanical device or artificial appliance which is of such character as could affect its performance or appearance at that event, Upon discovery of administration of such drug, medication, mechanical device or artificial appliance, show management shall immediately report the matter to AQHA. Any action or substance, administered internally or externally, whether drugs or otherwise, which may interfere with the testing procedure, or mask or screen the presence of such drug, is forbidden.

The above prohibition includes application or administration of any drug, chemical, foreign substance, surgical procedure, or trauma, accidental or intentional (as to trauma, this prohibition applies to horses foaled after January 1, 1990), which results in, or could result in, alteration of normal tail function, carriage, conformation or overall appearance of the horse.

Every exhibitor shall, upon request of show management or AQHA representative, permit a specimen of urine, saliva, blood or other substance to be taken for testing, and refusal to comply with such request shall constitute grounds for immediate disqualification of the horse from further participation at the show, shall bar the horse from participation in future AQHAapproved events or shows for such period as determined by the Executive Committee or other appropriate committee, and shall constitute grounds for suspension of AQHA membership. If the laboratory report on the chemical analysis of saliva, urine, blood or other sample taken from the horse indicates the presence of a forbidden drug or medication, this shall be taken as prima cie evidence such substance has been administered to the horse either internally or externally.

THE GUIDELINES, IF NEEDED, WILL MINIMIZE THE CHANCES OF POSITIVE DRUG TESTS. HOWEVER, ALL RESPONSIBLE PARTIES ARE CAUTIONED THAT THE GUIDELINES ARE ONLY GENERAL GUIDELINES, AND IT IS THEIR RESPONSIBILITY TO SEE TO IT THAT CONDITIONS PREVAIL FOR FULL COMPLIANCE WITH ALL AQHA RULES. RELIANCE UPON THE GUIDELINES WILL NOT SERVE AS A DEFENSE TO A CHARGE OF VIOLATION OF THE RULE IN THE EVENT OF A POSITIVE DRUG TEST.

schooling over ramped oxers in reverse order (i.e., from highest to lowest instead of lowest to highest);

Upon receipt of this report, at the owners expense, AQHA may require a veterinarian examination that becomes a part of the horses file. The veterinarian must be approved by AQHA.

Every owner, exhibitor and/or absolutely responsible person shall, upon request of show management or AQHA representative, permit examination of a horse for determination of the presence of prohibited surgery, foreign drug or substance and normal tail function, and refusal to comply with such request shall constitute grounds for immediate disqualification of the horse from further participation at the show, or from further approved events pending hearing; shall bar the horse from participation in future approved events or shows for such period as determined by the Executive Committee or other appropriate committee; and shall constitute grounds for suspension of AQHA membership of the owner, exhibitor and/or absolutely responsible person.

In the case of trauma to a horses tail which does alter or could result in alteration of tail function, to shorten the stipulated one year period prior to consideration for reinstatement provided below, the owner shall file a written report concerning the injury and its circumstance with AQHA within 30 days of the occurrence.

Identification of the medication: the name, amount, strength/concentration and mode of administration.

AQHA members, nonmembers, exhibitors, trainers, owners, owner representatives, spectators and all other persons on the show grounds of an AQHAapproved event; and

When phenylbutazone is administered, the dose should be accurately calculated according to the actual weight of the animal. Each 24 hours, not more than 2.0 milligrams per pound of body weight should be administered, preferably less. For a 1,000 pound animal, the maximum daily dose is 2.0 grams, which equals two 1.0 gram tablets, or two 1.0 gram units of paste, or 10.0 cc of the injectable (200 milligrams per milliliter). Neither a total daily dose nor part of an injectable dose should be administered during the 12 hours prior to competing. In the event the phenylbutazone is administered orally, half of the maximum daily dose (1.0 gram per 1,000 lbs) can be administered each 12 hours (i.e., 12 hours apart) during a five day treatment program even if such oral administration occurs within 12 hours of competition. Phenylbutazone should not be used for more than five successive days.

Regardless of whether all of the conditionally permitted therapeutic medication requirements for a specific NSAID listed in section (3)(C)(18) below are met, it shall be considered a rule violation if the same plasma or urine sample contains more than one (1) of the NSAIDs listed in section (3)(C)(18) below.

(an NSAID) The maximum permitted plasma concentration of Diclofenac (Surpass) is 0.005 micrograms per milliliter.

Should the testing laboratory report the presence of one of the drugs or medications listed in section (3)(C)(113) below in an amount greater than what would be consistent with the Guidelines or at a level higher than a specified maximum permitted plasma concentration, the matter will be reviewed and disciplinary action may be taken.

Any substance, regardless of how harmless or innocuous it might be, that might interfere with the detection or quantitation of any substance defined in (A)(B) or (C).

Show management may immediately expel individuals exhibiting unsportsmanlike conduct from show grounds and shall file a written report with AQHA concerning the conduct in question.

Any metabolite and/or analog of any of the above described forbidden drugs or substances.

use of training techniques or methods such as poling or striking a horses legs with objects;

When Flunixin Meglumine (Banamine®) is administered, the dose should be accurately calculated according to the actual weight of the animal. Each 24 hours, not more than 0.5 milligrams per pound of body weight should be administered. For a 1,000 pound animal, the maximum daily dose is 500 milligrams, which equals two 250 milligram packets of granules, or one 500 milligram packet of granules, or 500 milligrams of the oral paste (available in 1,500 milligram dose syringes), or 10.0 cc of the injectable (50 milligrams per milliliter). No part of a dose should be administered during the twelve (12) hours prior to competing. Any medicated feed must be consumed and/or removed at least twelve (12) hours prior to competing. The medication should not be used for more than five successive days.